Table 5 Number (N) and frequency (%) of MAEs, according to the pharmacological class of the administered medication (ATCC, WHO, 2020)
ATCC classification of medicinal products | Error | Total | ||||
|---|---|---|---|---|---|---|
No | Yes | |||||
N | % | N | % | N | % | |
M—musculoskeletal system | 3 | 50.0 | 3 | 50.0 | 6 | 100.0 |
S—sense organs | 4 | 57.1 | 3 | 42.9 | 7 | 100.0 |
A—digestive system and metabolism | 87 | 58.4 | 62 | 41.6 | 149 | 100.0 |
J—general anti-infectives for systemic use | 44 | 58.7 | 31 | 41.3 | 75 | 100.0 |
N—nervous system | 87 | 58.8 | 61 | 41.2 | 148 | 100.0 |
C—cardiovascular system | 45 | 73.8 | 16 | 26.2 | 61 | 100.0 |
B—blood and hematopoietic organs | 57 | 74.0 | 20 | 26.0 | 77 | 100.0 |
R—respiratory system | 8 | 88.9 | 1 | 11.1 | 9 | 100.0 |
H—systemic hormonal preparations* | 16 | 94.1 | 1 | 5.9 | 17 | 100.0 |
Other | 7 | 58.3 | 5 | 41.7 | 12 | 100.0 |
Total | 358 | 63.8 | 203 | 36.2 | 561 | 100.0 |